Ideagen software helps WHO during socially-distant global assembly
Regulated information management software company Ideagen announced a partnership with the World Health Organization (WHO) on Friday, to support its collaboration and policy-making work with member states and other interested bodies during the Covid-19 coronavirus pandemic.
The AIM-traded firm noted that the 73rd annual World Health Assembly took place earlier in the week, explaining that in “normal times” there would be more than 60 items on the agenda for discussion.
This year, however, there were just two, with the main one being Covid-19 and the global response to it.
The assembly was due to be attended by delegations from the 194 member states of the WHO, as well as non-governmental organisations, philanthropic organisations and other interested parties.
This year, many delegations were led by heads of states, and the number of people attending was expected to be around 4,000.
Usually, the meeting would involve face-to-face gatherings and discussions in the Palais de Nation in Geneva, but social distancing measures meant that was impossible.
Ideagen said its document collaboration and governance software, ‘PleaseReview’, provided the WHO with a solution to those problems.
It explained that PleaseReview allowed for the real-time collaboration on documents, offered a secure means of capturing comments, and provided a “full audit trail” of responses, changes and agreements.
“PleaseReview is working with the World Health Organization in support of WHO's Covid-19 outbreak response, by providing services to WHO on a pro bono basis to allow WHO to conduct its first-ever digital World Health Assembly,” a spokesperson for the World Health Organization confirmed.
Adopting PleaseReview meant the WHO could invite member states to conduct a first review of policy documents, which would normally be conducted face-to-face, in a secure, online environment.
As well as ensuring social distancing was maintained, it also saved a “huge amount” of time, which Ideagen said was “incredibly valuable” during the current, uncertain period.
“We are delighted to support the WHO in their life saving work, especially at such a crucial period,” said chief executive officer Ben Dorks.
“Everyone at Ideagen has enormous respect for the work being done by the WHO, both in the fight against coronavirus and in their ongoing efforts to tackle other global health issues.
“The scale of the challenge facing them is enormous and we are extremely proud that we can offer them the use of PleaseReview, a product that will make that challenge a little easier to handle.”
At 1340 BST, shares in Ideagen were up 7.78% at 187p.